Y
Yina Wang
Researcher at Zhejiang University
Publications - 4
Citations - 195
Yina Wang is an academic researcher from Zhejiang University. The author has contributed to research in topics: Lung cancer & Pile. The author has an hindex of 3, co-authored 4 publications receiving 102 citations.
Papers
More filters
Journal ArticleDOI
Tensile force of geogrids embedded in pile-supported reinforced embankment: A full-scale experimental study
TL;DR: In this paper, a full-scale high-speed railway embankment model was established for assessment of the tensile force of the geogrid embedded in the sand cushion, and water bags were distributed around pile caps to create a model of the subsoil.
Journal ArticleDOI
Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy
Caicun Zhou,Yina Wang,Jun Zhao,Gongyan Chen,Zhihua Liu,Kangsheng Gu,Meijuan Huang,Jianxing He,Jianhua Chen,Zhiyong Ma,Jifeng Feng,Jianhua Shi,Xinmin Yu,Ying Cheng,Yu Yao,Yuan Chen,R. Guo,Xiaoyan Lin,Zhe-Hai Wang,Guanghui Gao,Quan Ren Wang,Weixia Li,Xinfeng Yang,Lihong Wu,Jun Zhang,Shengxiang Ren +25 more
TL;DR: Combined apatinib and camrelizumab showed encouraging antitumor activity and acceptable toxicity in chemotherapy-pretreated patients with advanced nonsquamous NSCLC, and appeared to be improved in patients with STK11/KEAP1 mutation.
Journal ArticleDOI
Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study
Chang Lu,Chang Lu,Xiao-Rong Dong,Jun Zhao,Xu-Chao Zhang,Hua-Jun Chen,Qing Zhou,Hai-Yan Tu,Xinghao Ai,Xiao-Feng Chen,Gai-Li An,Jun Bai,Jin-Lu Shan,Yina Wang,Shuanying Yang,Xiang Liu,Wu Zhuang,Hui-Ta Wu,Bo Zhu,Xuefeng Xia,Rongrong Chen,Dejian Gu,Huamin Xu,Yi-Long Wu,Yi-Long Wu,Jin-Ji Yang,Jin-Ji Yang +26 more
TL;DR: Patients with concurrent TP53 mutation or high peripheral blood TCR repertoire diversity have relatively inferior overall survival in this series, and outcomes with traditional systemic therapies in general are suboptimal.
Journal ArticleDOI
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study.
Jin-Ji Yang,Cheng Huang,Yun Fan,Hongming Pan,Jifeng Feng,Liyan Jiang,Xingya Li,Xiaoqing Liu,Jianping Xiong,Yanqiu Zhao,Ying Cheng,Rui Ma,Jie Wang,Yina Wang,Yan-Hui Liu,Dongmei Lin,Tao Wang,Wei Shi,Jianjun Zou,Yi-Long Wu +19 more
TL;DR: In this paper, the authors evaluated camrelizumab in different PD-L1 expression cohorts of patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC).